General announcements
Colorado’s Newborn Screening Panel
New disorders are coming soon to Colorado’s newborn screening panel!
On March 20, 2024, the Colorado Board of Health approved the addition of two disorders to the Colorado newborn screening panel for population screening:
- Guanidinoacetate Methyltransferase (GAMT) Deficiency
- Mucopolysaccharidosis Type II (MPS II)
Additionally, the Board approved targeted screening for congenital cytomegalovirus (cCMV) infection.
The rules will go into effect May 15, 2024. Screening for these conditions will begin once instrument procurement and validation testing are completed, and contacts are established for follow-up services. Continue to check back for updates.
Transition to E-Reports
CONBSP will no longer send out physical mailers or fax the daily reports for the newborn screen to any health facilities. The only exception is mailing abnormal reports. Reports can still be requested by phone or fax by submitting a completed results request form. Prior to calling or faxing, check E-portal. If the report is unavailable, contact the birthing facility.
Sign up for an E-report account to access the portal to obtain newborn screen reports.
If you are unable to access this document please contact cdphe_nbs_software@state.co.us.
Health care providers and laboratories
Abnormal Results | Education | Training | Quality Improvement (QI) | E-Report | Result Request | Corrections Request
Meeting Schedule | Newsletter | Disorders | QI | Policies
Common Questions | Sickle Cell Information | Disorders
Policies
- Clia license
- Sickle cell screening and National Collegiate Athletic Association (NCAA) rules
- NBS Retention Schedule
- HB18-1006 Newborn Screening
- Newborn screening rules and regulations
- Newborn Screening Fees for Providers
- Newborn Screening cCMV Sample Release Policy
- Please Note:
- CONBSP will accept all necessary newborn blood spot screenings for an infant up to 12 months of life.
- For refugee status, knowing the infant’s age will help with the interpretation of the results since they will be evaluated outside of the usual parameters.
Newborn Blood Spot Screening Phone: 303-692-3675 | Fax: 303-691-4008 | Email: cdphe_conbs@state.co.us